Qube Research & Technologies (QRT)
AERI

Qube Research & Technologies (QRT)’s Aerie Pharmaceuticals AERI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-221,266
Closed -$3.35M – 3196
2022
Q3 		$3.35M Buy
+221,266
New +$2.57M 0.02% 731
2022
Q1 		– Sell
-21,798
Closed -$153K – 3233
2021
Q4 		$153K Buy
+21,798
New +$228K ﹤0.01% 2045
2021
Q2 		– Sell
-12,819
Closed -$229K – 2972
2021
Q1 		$229K Buy
+12,819
New +$221K ﹤0.01% 1599

Qube Research & Technologies (QRT)'s AERI Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 221,266 shares — an estimated $3.35M sold.

Qube Research & Technologies (QRT) first reported a position in AERI in Q1 2021 and held it in 3 quarters. The position peaked at $3.35M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 221,266 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.35M.
  • Qube Research & Technologies (QRT) first reported a position in Aerie Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Aerie Pharmaceuticals position peaked at $3.35M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.